STUDY OBJECTIVE: We determine the rate and details of interventions associated with emergency medicine pharmacist review of discharge prescriptions for patients discharged from the emergency department (ED). Additionally, we evaluate care providers' satisfaction with such services provided by emergency medicine pharmacists. METHODS: This was a prospective observational study in the ED of an academic medical center that serves both adult and pediatric patients. Details of emergency medicine pharmacist interventions on discharge prescriptions were compiled with a standardized form. Interventions were categorized as error prevention or optimization of therapy. The staff of the ED was surveyed related to the influence and satisfaction of this new emergency medicine pharmacist-provided service. RESULTS: The 674 discharge prescriptions reviewed by emergency medicine pharmacists during the study period included 602 (89.3%) for adult patients and 72 (10.7%) for pediatric patients. Emergency medicine pharmacists intervened on 68 prescriptions, resulting in an intervention rate of 10.1% (95% confidence interval [CI] 8.0% to 12.7%). The intervention rate was 8.5% (95% CI 6.4% to 11.1%) for adult prescriptions and 23.6% for pediatric prescriptions (95% CI 14.7% to 35.3%) (difference 15.1%; 95% CI 5.1% to 25.2%). There were a similar number of interventions categorized as error prevention and optimization of medication therapy, 37 (54%) and 31 (46%), respectively. More than 95% of survey respondents believed that the new pharmacist services improved patient safety, optimized medication regimens, and improved patient satisfaction. CONCLUSION: Emergency medicine pharmacist review of discharge prescriptions for discharged ED patients has the potential to significantly improve patient care associated with suboptimal prescriptions and is highly valued by ED care providers.
STUDY OBJECTIVE: We determine the rate and details of interventions associated with emergency medicine pharmacist review of discharge prescriptions for patients discharged from the emergency department (ED). Additionally, we evaluate care providers' satisfaction with such services provided by emergency medicine pharmacists. METHODS: This was a prospective observational study in the ED of an academic medical center that serves both adult and pediatric patients. Details of emergency medicine pharmacist interventions on discharge prescriptions were compiled with a standardized form. Interventions were categorized as error prevention or optimization of therapy. The staff of the ED was surveyed related to the influence and satisfaction of this new emergency medicine pharmacist-provided service. RESULTS: The 674 discharge prescriptions reviewed by emergency medicine pharmacists during the study period included 602 (89.3%) for adult patients and 72 (10.7%) for pediatric patients. Emergency medicine pharmacists intervened on 68 prescriptions, resulting in an intervention rate of 10.1% (95% confidence interval [CI] 8.0% to 12.7%). The intervention rate was 8.5% (95% CI 6.4% to 11.1%) for adult prescriptions and 23.6% for pediatric prescriptions (95% CI 14.7% to 35.3%) (difference 15.1%; 95% CI 5.1% to 25.2%). There were a similar number of interventions categorized as error prevention and optimization of medication therapy, 37 (54%) and 31 (46%), respectively. More than 95% of survey respondents believed that the new pharmacist services improved patient safety, optimized medication regimens, and improved patient satisfaction. CONCLUSION: Emergency medicine pharmacist review of discharge prescriptions for discharged ED patients has the potential to significantly improve patient care associated with suboptimal prescriptions and is highly valued by ED care providers.
Authors: Parastou Donyai; Kara O'Grady; Ann Jacklin; Nick Barber; Bryony Dean Franklin Journal: Br J Clin Pharmacol Date: 2007-07-27 Impact factor: 4.335
Authors: Peter J Zed; Riyad B Abu-Laban; Robert M Balen; Peter S Loewen; Corinne M Hohl; Jeffrey R Brubacher; Kerry Wilbur; Matthew O Wiens; Leslie J Samoy; Katie Lacaria; Roy A Purssell Journal: CMAJ Date: 2008-06-03 Impact factor: 8.262
Authors: Eileen M Murphy; Carolyn J Oxencis; James A Klauck; Douglas A Meyer; Jill M Zimmerman Journal: Am J Health Syst Pharm Date: 2009-12-01 Impact factor: 2.637
Authors: Jeffrey M Rothschild; William Churchill; Abbie Erickson; Kristin Munz; Jeremiah D Schuur; Claudia A Salzberg; Daniel Lewinski; Rita Shane; Roshanak Aazami; John Patka; Rondell Jaggers; Aaron Steffenhagen; Steve Rough; David W Bates Journal: Ann Emerg Med Date: 2009-12-11 Impact factor: 5.721
Authors: Hani Abdelaziz; Rasha Al Anany; Ashraf Elmalik; Mohammad Saad; Kirti Prabhu; Haleema Al-Tamimi; Salem Abu Salah; Peter Cameron Journal: Int J Clin Pharm Date: 2016-03-31
Authors: Howard S Kim; Danielle M McCarthy; Jason A Hoppe; D Mark Courtney; Bruce L Lambert Journal: Acad Emerg Med Date: 2017-09-19 Impact factor: 3.451
Authors: Simone E Taylor; Elise A Mitri; Andrew M Harding; David McD Taylor; Adrian Weeks; Leonie Abbott; Pani Lambros; Dona Lawrence; Dana Strumpman; Reyhan Senturk-Raif; Stephen Louey; Hamish Crisp; Emily Tomlinson; Elizabeth Manias Journal: Front Pharmacol Date: 2022-07-06 Impact factor: 5.988
Authors: Niteesh K Choudhry; Thomas Isaac; Julie C Lauffenburger; Chandrasekar Gopalakrishnan; Marianne Lee; Amy Vachon; Tanya L Iliadis; Whitney Hollands; Sandra Elman; Jacqueline M Kraft; Samrah Naseem; Scott Doheny; Jessica Lee; Julie Barberio; Lajja Patel; Nazleen F Khan; Joshua J Gagne; Cynthia A Jackevicius; Michael A Fischer; Daniel H Solomon; Thomas D Sequist Journal: JAMA Intern Med Date: 2018-09-01 Impact factor: 21.873